RecallRadar

FDA Drug recall D-0868-2026

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured b…

On 2026-09-30 the FDA classified a Class II recall of Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured b… by Amneal Pharmaceuticals, citing defective Delivery System: Possibility of no medication in the prefilled pen.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0868-2026
ClassificationClass II
Statusongoing
Initiated2026-08-28
Published2026-09-30
Last updated2026-10-06 05:30 UTC
CompanyAmneal Pharmaceuticals
DistributionUS

Product

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Reason

Defective Delivery System: Possibility of no medication in the prefilled pen.

Identifiers

ndc70121-1685-1
ndc70121-1686-1
code_infoLot #: AP250095A, Exp 2/28/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-10-06 05:30 UTC. Current status: ongoing.

Other recalls by Amneal Pharmaceuticals

All Amneal Pharmaceuticals recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0868-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.